(Circulation. 1995;91:3010-3016.)
© 1995 American Heart Association, Inc.
Articles |
From Quebec Heart Institute, Laval Hospital and School of Pharmacy, Laval University, Ste-Foy, Quebec, Canada.
Correspondence to Jacques Turgeon, PhD, Quebec Heart Institute, Research Center, Laval Hospital, 2725, Chemin Ste-Foy, Ste-Foy, Quebec, Canada, G1V 4G5.
Background Administration of erythromycin to humans has been associated with lengthening of cardiac repolarization and even proarrhythmia. The objectives of our study were to describe effects of erythromycin on repolarization of isolated hearts and to determine effects of the drug on major K+ currents involved in cardiac repolarization.
Methods and Results A first set of experiments was conducted in isolated, buffer-perfused guinea pig hearts electrically stimulated at a basic cycle length of 250 ms. In this model, erythromycin 10-4 mol/L increased monophasic action potential duration measured at 90% repolarization (MAPD90) by 40±7 ms. Increase in MAPD90 was reproducibly observed in seven hearts studied. To study the mechanism of these effects on cardiac repolarization, a second set of experiments was performed in isolated guinea pig ventricular myocytes using the whole cell configuration of the patch-clamp technique. In these cells, erythromycin 10-4 mol/L decreased by about 40% (P<.05 versus baseline) the time-dependent outward K+ current elicited by short depolarizations (250 ms) to low depolarizing voltages (-20 to 0 mV). In contrast, the drug was without significant effects on the time-dependent K+ current elicited by long pulses (5000 ms) to high depolarizing voltages (+10 to +50 mV), on the time-independent background current (mostly IK1), and on the slow inward calcium current.
Conclusions The outward time-dependent K+ current blocked by erythromycin in isolated guinea pig ventricular myocytes had characteristics similar to those described for IKr. Selective block of this component of IK gives an explanation for the effects of erythromycin on cardiac repolarization. These effects were observed at clinically relevant concentrations reached after intravenous administration of the drug and warn for potential interactions with other action potentiallengthening drugs.
Key Words: action potentials potassium torsade de pointes calcium channels
This article has been cited by other articles:
![]() |
H. Itoh, T. Sakaguchi, W.-G. Ding, E. Watanabe, I. Watanabe, Y. Nishio, T. Makiyama, S. Ohno, M. Akao, Y. Higashi, et al. Latent Genetic Backgrounds and Molecular Pathogenesis in Drug-Induced Long-QT Syndrome Circ Arrhythm Electrophysiol, October 1, 2009; 2(5): 511 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch, L. Belardinelli, L. Wu, H. Fraser, A. C. Zygmunt, A. Burashnikov, J. M. Di Diego, J. M. Fish, J. M. Cordeiro, R. J. Goodrow Jr, et al. Electrophysiologic Properties and Antiarrhythmic Actions of a Novel Antianginal Agent Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S65 - S83. [Abstract] [PDF] |
||||
![]() |
W.S. Redfern, L. Carlsson, A.S. Davis, W.G. Lynch, I. MacKenzie, S. Palethorpe, P.K.S. Siegl, I. Strang, A.T. Sullivan, R. Wallis, et al. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development Cardiovasc Res, April 1, 2003; 58(1): 32 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-E. Chiang, H.-N. Luk, T.-M. Wang, and P. Y.-A. Ding Effects of sildenafil on cardiac repolarization Cardiovasc Res, August 1, 2002; 55(2): 290 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450. [PDF] |
||||
![]() |
B. Drolet, G. Rousseau, P. Daleau, R. Cardinal, and J. Turgeon Domperidone Should Not Be Considered a No-Risk Alternative to Cisapride in the Treatment of Gastrointestinal Motility Disorders Circulation, October 17, 2000; 102(16): 1883 - 1885. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ohtani, C. Taninaka, E. Hanada, H. Kotaki, H. Sato, Y. Sawada, and T. Iga Comparative Pharmacodynamic Analysis of Q-T Interval Prolongation Induced by the Macrolides Clarithromycin, Roxithromycin, and Azithromycin in Rats Antimicrob. Agents Chemother., October 1, 2000; 44(10): 2630 - 2637. [Abstract] [Full Text] |
||||
![]() |
P. Geelen, B. Drolet, J. Rail, J. Berube, P. Daleau, G. Rousseau, R. Cardinal, G. E. O'Hara, and J. Turgeon Sildenafil (Viagra) Prolongs Cardiac Repolarization by Blocking the Rapid Component of the Delayed Rectifier Potassium Current Circulation, July 18, 2000; 102(3): 275 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Drolet, A. Emond, B. Pharm, V. Fortin, P. Daleau, G. Rousseau, R. Cardinal, and J. Turgeon Vitamin K Modulates Cardiac Action Potential by Blocking Sodium and Potassium Ion Channels Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(4): 267 - 273. [Abstract] [PDF] |
||||
![]() |
M. Khalifa, P. Daleau, and a. J. Turgeon Mechanism of Sodium Channel Block by Venlafaxine in Guinea Pig Ventricular Myocytes J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 280 - 284. [Abstract] [Full Text] |
||||
![]() |
L. M. Shuba, Y. Kasamaki, S. E. Jones, T. Ogura, J. R. McCullough, and T. F. McDonald Action Potentials, Contraction, and Membrane Currents in Guinea Pig Ventricular Preparations Treated with the Antispasmodic Agent Terodiline J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1417 - 1426. [Abstract] [Full Text] |
||||
![]() |
A. Mishra, H. S. Friedman, and A. K. Sinha The Effects of Erythromycin on the Electrocardiogram Chest, April 1, 1999; 115(4): 983 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Khalifa, B. Drolet, P. Daleau, C. Lefez, M. Gilbert, S. Plante, G. E. O'Hara, O. Gleeton, B. A. Hamelin, and J. Turgeon Block of Potassium Currents in Guinea Pig Ventricular Myocytes and Lengthening of Cardiac Repolarization in Man by the Histamine H1 Receptor Antagonist Diphenhydramine J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 858 - 865. [Abstract] [Full Text] |
||||
![]() |
R. M. Ward, J. A. Lemons, and R. A. Molteni Cisapride: A Survey of the Frequency of Use and Adverse Events in Premature Newborns Pediatrics, February 1, 1999; 103(2): 469 - 472. [Abstract] [Full Text] |
||||
![]() |
P. Geelen, B. Drolet, E. Lessard, P. Gilbert, G. E. O'Hara, and J. Turgeon Concomitant Block of the Rapid (IKr) and Slow (IKs) Components of the Delayed Rectifier Potassium Current is Associated With Additional Drug Effects on Lengthening of Cardiac Repolarization Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1999; 4(3): 143 - 150. [Abstract] [PDF] |
||||
![]() |
B. Drolet, M. Khalifa, P. Daleau, B. A. Hamelin, and J. Turgeon Block of the Rapid Component of the Delayed Rectifier Potassium Current by the Prokinetic Agent Cisapride Underlies Drug-Related Lengthening of the QT Interval Circulation, January 20, 1998; 97(2): 204 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. West, D. K. Martin, J. A. Bursill, K. R. Wyse, and T. J. Campbell Comparative Study of the Effects of Erythromycin and Roxithromycin on Action Potential Duration and Potassium Currents in Canine Purkinje Fibers and Rabbit Myocardium Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(1): 29 - 36. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |